PAGE FOR USERS

Contract Development and GMP Manufacturing of Advanced Cell Therapies

GaiaCell provides comprehensive CDMO (Contract Development and Manufacturing Organization) services for the development, optimization, and GMP manufacturing of advanced cell therapies, with a strong focus on clinical translation, regulatory compliance, and long-term partnership.

Establish Collaboration

Who Are We as a CDMO?


GaiaCell operates as a specialized Contract Development and Manufacturing Organization (CDMO) in the field of advanced cell therapies. Our CDMO activities are based on direct experience gained through the development, manufacturing, and clinical application of our own cell therapy products within a regulated GMP environment.
This dual approach—simultaneously acting as both developer and manufacturer—enables us to offer partners practical, realistic, and clinically oriented solutions that go beyond the mere technical execution of manufacturing.

WHY GAIA CELL

Why Choose GaiaCell as Your CDMO Partner?

1
Direct experience in the development and manufacturing of proprietary cell therapy programs.
2
Specialization in advanced cell therapies and a clinically oriented, pragmatic development approach.
3
GMP infrastructure and regulatory maturity.
4
Long-term, transparent, and partnership-based collaborations.

OUR CDMO SERVICES


Comprehensive Support Throughout the Entire Product Lifecycle


Our CDMO services cover all key stages of advanced cell therapy development and manufacturing:

  • development and optimization of manufacturing processes,
  • technology transfer from research to a GMP environment,
  • GMP manufacturing of cell therapies for clinical use,
  • process scaling and manufacturing cost optimization,
  • development and validation of analytical methods (QA/QC),
  • stability studies and product characterization.

All activities are conducted in accordance with applicable regulatory requirements, EU GMP guidelines, and established quality standards.

OUR APPROACH


A Structured and Partnership-Based Way of Working


Each project is treated individually. Together with our partners, we design a development and manufacturing strategy tailored to the specific objectives, timelines, and regulatory requirements of the project.
Our approach is based on:

  • close and transparent collaboration with the client,
  • clear definition of development phases and responsibilities,
  • early identification and management of technical and regulatory risks,
  • a strong focus on clinical applicability and final product quality.

GMP INFRASTRUCTURE


GMP-Compliant Manufacturing


Cell therapy manufacturing is performed in certified cleanrooms designed and operated in accordance with Good Manufacturing Practice (GMP) principles and relevant European guidelines.
Our infrastructure enables:

  • GMP-compliant manufacturing of cell therapies for clinical use,
  • controlled manufacturing and storage conditions,
  • full traceability of materials, processes, and products throughout the entire production flow,
  • quality control of intermediate and final products within an established quality management system.

Komu je namenjeno?

Clinical research groups
Biotechnology companies
The pharmaceutical industry
Research and translational consortia

Let’s Talk About Your Project


Contact us and together we will define the optimal development and manufacturing strategy for your project.

Establish Collaboration
crossmenu